Retrospective evaluation of interventional treatment of peripheral slow-flow malformations using image-guided bleomycin electrotherapy.

Retrospective evaluation of interventional treatment of peripheral slow-flow malformations using image-guided bleomycin electrotherapy. - BEST

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031072

Enrollment

300

Registered

2023-02-16

Start date

2023-01-23

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q89

Interventions

Group 1: It is a retrospective study design in which all the data to be analyzed are already available.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of combined slow-flow peripheral vascular malformation (capillary-venous malformation, CVM; capillary-lymphatic malformation, CLM; lymphatic-venous malformation, LVM; capillary-lymphatic-venous malformation, CLVM) and who have undergone imaging-guided treatment by a Bleomycin electro-sclerotherapy (BEST) in the form of one or more sessions in the period from 01.01.2020 to 30.12.2022

Exclusion criteria

Exclusion criteria: Patients with other vascular anomalies (high-flow malformations) or vascular tumors Patients who have received the above procedures with other image-guided sclerotherapy/embolization techniques, e.g. B. Polidocanol sclerotherapy

Design outcomes

Primary

Measure	Time frame
Analysis of the complication rate after interventional treatment using image-guided bleomycin electro-sclerotherapy (BEST) of simple or mixed peripheral slow-flow malformations (peri-interventional and post-interventional complications < 30 days)	—

Secondary

Measure	Time frame
Analysis of the technical success after interventional treatment using image-guided bleomycin electro-sclerotherapy (BEST) of simple or mixed peripheral slow-flow malformations (successful execution of the interventions)	—

Countries

Germany

Contacts

Public ContactVanessa Schmidt

LMU München

vanessa.schmidt@med.uni-muenchen.de+4989440076642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026